Catalytic Asymmetric Dihydroxylation of Olefins with Reusable OsO(4)(2-) on Ion-exchangers: the Scope and Reactivity Using Various Cooxidants
Overview
Affiliations
Exchanger-OsO(4) catalysts are prepared by an ion-exchange technique using layered double hydroxides and quaternary ammonium salts covalently bound to resin and silica as ion-exchangers. The ion-exchangers with different characteristics and opposite ion selectivities are specially chosen to produce the best heterogeneous catalyst that can operate using the various cooxidants in the asymmetric dihydroxylation reaction. LDH-OsO(4) catalysts composed of different compositions are evaluated for the asymmetric dihydroxylation of trans-stilbene. Resin-OsO(4) and SiO(2)-OsO(4) designed to overcome the problems associated with LDH-OsO(4) indeed show consistent activity and enantioselectivity in asymmetric dihydroxylation of olefins using K(3)Fe(CN)(6) and molecular oxygen as cooxidants. Compared to the Kobayashi heterogeneous systems, resin-OsO(4) is a very efficient catalyst for the dihydroxylation of a wide variety of aromatic, aliphatic, acyclic, cyclic, mono-, di-, and trisubstituted olefins to afford chiral vicinal diols with high yields and enantioselectivities irrespective of the cooxidant used. Resin-OsO(4) is recovered quantitatively by a simple filtration and reused for a number of cycles with consistent activity. The high binding ability of the heterogeneous osmium catalyst enables the use of an equimolar ratio of ligand to osmium to give excellent enantioselectives in asymmetric dihydroxylation in contrast to the homogeneous osmium system in which excess molar quantities of the expensive chiral ligand to osmium are invariably used. The complexation of the chiral ligand (DHQD)(2)PHAL, having very large dimension, a prerequisite to obtain higher ee, is possible only with the OsO(4)(2-) located on the surface of the supports.
Boosting Thermal Stability of Volatile Os Catalysts by Downsizing to Atomically Dispersed Species.
Kim J, Yoon S, Baek D, Kim J, Kim J, An K JACS Au. 2022; 2(8):1811-1817.
PMID: 36032528 PMC: 9400046. DOI: 10.1021/jacsau.2c00090.
Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold.
Gundluru M, Pourpak A, Cui X, Morris S, Webb T Medchemcomm. 2011; 2(9):904-908.
PMID: 21927710 PMC: 3171832. DOI: 10.1039/C1MD00040C.